Santa Cruz Biotechnology offers a broad range of PSG1 monoclonal antibodies for advanced research in immunology and reproductive biology. PSG1 monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Pregnancy-specific glycoprotein 1 (PSG1) plays a crucial role in immune modulation during pregnancy, contributing to the maintenance of fetal tolerance and the regulation of maternal immune responses. PSG1 expression is primarily associated with trophoblast cells and is involved in various biological processes, including cell adhesion and immune evasion. Understanding PSG1 function is essential for elucidating mechanisms underlying pregnancy complications and developing therapeutic strategies. Researchers worldwide utilize PSG1 monoclonal antibodies to explore the molecular mechanisms of pregnancy-related disorders. Current investigations focus on how PSG1 influences maternal-fetal tolerance and its potential as a biomarker for pregnancy complications. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of reproductive biology and contribute to the development of improved diagnostic and therapeutic approaches in maternal-fetal medicine.